-
EC eCQMs - Eligible Clinicians
-
Resolution: Done
-
Minor
-
None
-
Elissa Chandler
-
2677255354
-
NextGen Healthcare
-
-
CMS136v6/NQF0108
-
CMS136v5
-
high impacts measure development
QUESTION: CMS136v5
Per the specification for the Numerator the encounter performed “ends after end of $InitialADHDMedication”.
1. Does this mean that the medication must have a stop date and the encounter must be documented during or after the medication stop date? OR
2. Can the medication continue to be active without having a medication stop date and the encounter can be performed within the specified timeframe after the FIRST medication has been prescribed?
Example1:
Numerator 1:
• Patient has FIRST ADHD medication ($InitialADHDMedication) prescribed on 1/1/2016 which is within 60 days after the start of the measurement period with no medication stop date documented.
• Patient then has an encounter Office Visit on 1/20/2016 which is within 30 days after the FIRST ADHD medication ($InitialADHDMedication) prescribed on 1/1/2016.
• Will this patient meet Numerator even if there are no medication stop date documented?
Example2:
Numerator 1:
• Patient has FIRST ADHD medication ($InitialADHDMedication) prescribed on 1/1/2016 which is within 60 days after the start of the measurement period with medication stop date of 1/15/2016.
• Patient then has an encounter Office Visit on 1/20/2016 which is within 30 days after the stop date of 1/15/2016 of the FIRST ADHD medication ($InitialADHDMedication).
• Will this patient meet Numerator because it was performed within 30 days after the medication has been stopped?
Will your response also apply to Numerator Criteria 2 for any of the above examples?